Functionalized graphene based electrochemical sensor array

Abstract

The invention relates to a functionalized graphene based electrochemical sensor array. The electrochemical sensor array comprises an electrode, a reduced graphene probe provided with stable BSA and modified on the surface of the electrode, and a calf thymus DNA functionalized reduced graphene probe, wherein the concentration of the reduced graphene probe with stable BSA is identical with that of the calf thymus DNA functionalized reduced graphene probe. The sensor array platform can be used for distinguishing different cancer cells and different states of the same cancer cell such as drug-resistant breast cancer cells and metastatic breast cancer cell specimens; the sensor identification unit is designed to perform simulation interaction with the cells, and combined with the electrochemical method with the ultrahigh sensitivity, so that the detection performance of the sensor can be obviously improved; furthermore, the electrochemical sensor array can be used for distinguishing different cells at 100-cell level; the detection accuracy can be up to 100%; the limit of detection of the cancer cells in the single type can be up to that of the single cell level.

Description

technical field [0001] The invention relates to an electrochemical sensor, in particular to an electrochemical sensor array based on functionalized graphene. Background technique [0002] Although a lot of energy and scientific research funds have been invested in cancer research all over the world, cancer is still one of the main causes of death and brings huge losses to society and economy. Although many advanced cancer treatment methods have been developed in the past decades, early diagnosis of cancer is still the key to cancer treatment. Rapid diagnosis and early intervention before the cancer spreads can control the development of the disease in time, which can not only reduce cancer mortality, improve the quality of life of patients, but also reduce medical expenses. The early detection of cancer is usually aimed at the analysis of tumor markers, which are indicative chemical substances to evaluate the occurrence and development of cancer and the effect of drug treat...

AI Technical Summary

Problems solved by technology

However, screening specific ligands (such as ligand system evolution by exponential enrichment in vitro, SELEX) and constructing special sensors are often time-consuming and expensive, and require a certain understanding of the specific biomarkers used

Development in this field has been severely limited by the difficulty of finding a specific marker that can differentiate between cancer cells or between specific cancer cells and their metastatic status

Images